Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-22-015250
Filing Date
2022-12-22
Accepted
2022-12-22 18:00:15
Documents
1
Period of Report
2022-12-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-57930.html 4  
1 PRIMARY DOCUMENT marketforms-57930.xml 4 3883
  Complete submission text file 0001214659-22-015250.txt   5336
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Issuer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address
Soffer Donald M (Reporting) CIK: 0001845860 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40060 | Film No.: 221482986